We are live on ! Find out more
BMRA icon

Biomerica

26 hedge funds and large institutions have $7.01M invested in Biomerica in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.73% less ownership

Funds ownership: 19.61%18.88% (-0.73%)

7% less funds holding

Funds holding: 2826 (-2)

25% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 8

25% less call options, than puts

Call options by funds: $6K | Put options by funds: $8K

38% less capital invested

Capital invested by funds: $11.3M → $7.01M (-$4.25M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
26
Holders Change
-2
Holders Change %
-7.14%
% of All Funds
0.44%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
6
Reduced
8
Closed
2
Calls
$6K
Puts
$8K
Net Calls
-$2K
Net Calls Change
-$784K

BMRA Hedge Fund Activity: Q2 2022 in Review

26 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Biomerica (BMRA) for Q2 2022, worth a combined $7.01M — down 38% from $11.3M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of BMRA and 0 opened new positions — a net loss of 2 holders — while 8 trimmed existing stakes and 6 added.

The largest buyer was Susquehanna International Group, adding an estimated $69.3K. The largest seller was Granahan Investment Management, cutting an estimated $239K.

  • 26 institutional investors held Biomerica (BMRA) as of Q2 2022, down from 28 in Q1 2022.
  • Funds reported $7.01M of Biomerica stock for Q2 2022, down 38% quarter-over-quarter.
  • 0 funds opened new Biomerica positions in Q2 2022 and 2 closed out, a net change of -2 holders.
  • The largest Biomerica buyer in Q2 2022 was Susquehanna International Group, an estimated $69.3K added.
  • The largest Biomerica seller in Q2 2022 was Granahan Investment Management, an estimated $239K sold.

Based on aggregated 13F filings for Q2 2022.